Effect of Accelerated RTH in Squamous Cell Carcinoma in Head and Neck
NCT05291663 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2022-03-23
Summary
Evaluation of the efficacy of the accelerated radiotherapy in squamous cell carcinoma of head and neck
Conditions
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Mostafa El-sayed Abd Elwanis · Assiut University
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-20
- Primary Completion
- 2023-03-20
- Completion
- 2023-12-20
More Related Trials
-
Study of 3-Dimensional Conformal Radiotherapy (3D-CRT) Versus Intensity Modulated Radiotherapy (IMRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT00652613 ·Status: UNKNOWN ·Phase: PHASE2
-
Accelerated Fractionation Radiotherapy (AFRT) Versus Concurrent Chemoradiotherapy (Crt) In Locally Advanced Head And Neck Squamous Cell Carcinoma
NCT01291095 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of SBRT for Squamous Cell Carcinoma of the Head and Neck
NCT04435938 ·Status: UNKNOWN ·Phase: PHASE2
-
Very Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCC
NCT00162708 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer
NCT05050162 ·Status: SUSPENDED ·Phase: PHASE2/PHASE3
-
Low-dose Radiotherapy Plus Tislelizumab in Combination With Afatinib for Neoadjuvant Treatment of Surgically Resectable Head and Neck Squamous Carcinoma
NCT06494189 ·Status: COMPLETED ·Phase: PHASE1
-
A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC
NCT03678649 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Cetuximab With Concomitant-boost Radiotherapy in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
NCT00865098 ·Status: COMPLETED ·Phase: PHASE2
-
Rituximab Plus Chemotherapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
NCT04361409 ·Status: COMPLETED ·Phase: PHASE1
-
Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer
NCT02388932 ·Status: TERMINATED ·Phase: NA
-
Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNN
NCT01884259 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Study Exploring Five Fractions of Post-operative Radiation Therapy in Head and Neck Cancer
NCT05648461 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Definitive Concurrent Hypofractionated Rth With Weekly Cisplatin in Locally Advanced SCCHN
NCT03880396 ·Status: COMPLETED
-
Concurent Chemoradiotherapy in Head and Neck Cancers
NCT04780750 ·Status: UNKNOWN ·Phase: PHASE3
-
Nasopharyngeal Carcinoma Post IMRT
NCT02597426 ·Status: ACTIVE_NOT_RECRUITING
-
Induction Chemotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT03815903 ·Status: RECRUITING ·Phase: PHASE3
-
Postoperative Concurrent Chemoradiotherapy With Docetaxel for High-Risk Squamous Cell Carcinoma of Head and Neck
NCT02776137 ·Status: COMPLETED ·Phase: PHASE2
-
Cetuximab With Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck in Chinese Subjects
NCT01012258 ·Status: COMPLETED ·Phase: PHASE3
-
Involved Field Elective Volume De-Intensification Radiation Therapy for Head and Neck Cancer
NCT03067610 ·Status: COMPLETED ·Phase: PHASE2
-
RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
NCT00956007 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Radiotherapy in Combination With Atezolizumab Prior to Surgical Resection for HPV Unrelated HNSCC
NCT05053737 ·Status: COMPLETED ·Phase: PHASE1
-
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
NCT02734537 ·Status: RECRUITING ·Phase: PHASE2
-
Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT01086826 ·Status: COMPLETED ·Phase: PHASE3
-
Radiation Therapy and Cetuximab in Treating Patients With Recurrent Head and Neck Cancer
NCT00891904 ·Status: TERMINATED ·Phase: NA
-
Prognostic Impact of Tumor Growth Velocity in Head and Neck Squamous Cell Carcinoma Treated by Radio(Chemo)Therapy
NCT02990936 ·Status: NOT_YET_RECRUITING